EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Association of serum AFP trajectories and hepatocellular carcinoma outcomes after hepatic arterial infusion chemotherapy: A longitudinal, multicenter study

Chao An iD, Ran Wei, Wang Yao iD, Wenwen Han, Wang Li, Ge Shi, Peihong Wu iD

Cancer Medicine · 2024

DOI: 10.1002/cam4.7319 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Cancer Medicine, 2024. Verfasst von Chao An und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Minimal Invasive Intervention, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Su…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, alpha-Fetoproteins, Infusions, Intra-Arterial. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

This study aims to investigate α‐fetoprotein (AFP) trajectories for prediction of survival outcomes after hepatic arterial infusion chemotherapy (HAIC) treatment in large hepatocellular carcinoma (HCC).

Methods

From May 2014 to June 2020, 889 eligible patients with large HCC underwent HAIC were retrospectively enrolled from five hospitals. A latent class growth mixed (LCGM) model was applied to distinguish potential AFP level dynamic changing trajectories. Inverse‐probability‐of‐treatment weighted (IPTW) analyses were performed to eliminate unmeasured confounders through marginal structural models. Multivariate Cox proportional hazard regression analyses were used to determine the overall survival (OS) in patients with large HCC. Performance of these serum markers for survival prediction was compared by areas under receiver operating characteristic analysis with the Delong test.

Results

The median follow‐up time was 23.7 (interquartile range, 3.8–115.3). A total of 1009 patients with large HCC, who underwent HAIC with AFP repeatedly measured 3–10 times, were enrolled in the study. Three distinct trajectories of these serum AFP were identified using the LCGM model: high stable (37.0%; n = 373), low stable (15.7%; n = 159), and sharp‐falling (47.3%; n = 477). Multivariate Cox proportional hazard regression analyses found that ALBI stage 2–3, BCLC‐C stage and high‐stable AFP trajectories were associated with OS. AFP trajectories yield the optimal predictive performance in all risk factors.

Conclusions

The AFP trajectories based on longitudinal AFP change showed outstanding performance for predicting survival outcomes after HAIC treatment in large HCC, which provide a potential monitoring tool for improving clinical decision‐making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver Neoplasmsalpha-FetoproteinsInfusions, Intra-ArterialHumansMaleFemaleMiddle AgedRetrospective StudiesLongitudinal StudiesAgedAntineoplastic Combined Chemotherapy ProtocolsHepatic ArteryBiomarkers, TumorTreatment OutcomePrognosis

Stichwörter der Autor:innen

AFP trajectorieshepatic arterial infusion chemotherapyhepatocellular carcinomasurvival outcomesthe latent class growth mixed model

Substanzen

alpha-FetoproteinsAFP protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Minimal Invasive Intervention, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China.
  • Department of Gastrointestinal Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Department of Interventional Oncology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.
  • Department of International Radiology and Vascular Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, China.
  • Medical Cosmetic and Plastic Surgery Center, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.

ORCID-Profile: Chao An, Wang Yao, Peihong Wu

Zitieren

APA

An, C., Wei, R., Yao, W., Han, W., Li, W., Shi, G., & Wu, P. (2024). Association of serum AFP trajectories and hepatocellular carcinoma outcomes after hepatic arterial infusion chemotherapy: A longitudinal, multicenter study. Cancer Medicine. https://doi.org/10.1002/cam4.7319

Vancouver

An C, Wei R, Yao W, Han W, Li W, Shi G, et al. Association of serum AFP trajectories and hepatocellular carcinoma outcomes after hepatic arterial infusion chemotherapy: A longitudinal, multicenter study. Cancer Medicine. 2024. doi:10.1002/cam4.7319

BibTeX
@article{An2024,
  author = {An, Chao and Wei, Ran and Yao, Wang and Han, Wenwen and Li, Wang and Shi, Ge and Wu, Peihong},
  title = {Association of serum AFP trajectories and hepatocellular carcinoma outcomes after hepatic arterial infusion chemotherapy: A longitudinal, multicenter study},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.7319}
}
Kostenlos starten →